IOVS AJP: Gastrointestinal and Liver Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Doherty, E. J.
Right arrow Articles by Engle, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doherty, E. J.
Right arrow Articles by Engle, E. C.
(Investigative Ophthalmology and Visual Science. 1999;40:1687-1694.)
© 1999 by The Association for Research in Vision and Ophthalmology, Inc.

CFEOM3: A New Extraocular Congenital Fibrosis Syndrome that Maps to 16q24.2-q24.3

Edward J. Doherty1, Margaret E. Macy2, Susan M. Wang2, Catherine P. Dykeman1, Maureen T. Melanson1 and Elizabeth C. Engle2,3

1 From the Department of Ophthalmology, Atlantic Health Sciences Corporation, Saint John, New Brunswick, Canada; 2 Division of Genetics and 3 Department of Neurology, Children’s Hospital, Harvard Medical School, Boston, Massachusetts.

PURPOSE. To define the clinical characteristics and determine the gene localization for a previously undescribed form of congenital fibrosis of the extraocular muscles (CFEOM), referred to as CFEOM type 3 (CFEOM3).

METHODS. A large family with CFEOM was identified, and participating individuals underwent ophthalmologic examination and donated blood for genetic analysis. The family’s disorder was tested for linkage to the known CFEOM loci, followed by a genome-wide search and linkage refinement using polymorphic DNA markers.

RESULTS. Thirty-eight members of this Canadian family participated in the study. Affected individuals are born with a nonprogressive eye movement disorder characterized by variable expression of ptosis and restrictive external ophthalmoplegia. Severely affected individuals have ptosis, primary gaze fixed in a hypo- and exotropic position, and marked restriction of eye movement bilaterally. Mildly affected individuals have normally positioned globes with a limitation of vertical gaze. Moderately affected individuals have asymmetrical involvement with one eye severely and one eye mildly affected. The disorder is autosomal dominant with variable expression and probable incomplete penetrance. Genetic analysis reveals linkage to markers on 16q24.2-q24.3. A maximum lod score of 5.8 occurs at markers D16S3063 and D16S689, and the CFEOM3 disease gene is located within a {approx}5.6-cM region flanked by D16S486 and D16S671.

CONCLUSIONS. These data establish that CFEOM3 is a phenotypically variant and genotypically distinct form of CFEOM with linkage to chromosome 16qter. The authors have previously demonstrated that CFEOM1 results from a developmental absence of the superior division of the oculomotor nerve. The authors hypothesize that CFEOM3 results from a defect analogous to, but distinct from, CFEOM1.




This article has been cited by other articles:


Home page
Arch OphthalmolHome page
S. Lu, C. Zhao, K. Zhao, N. Li, and C. Larsson
Novel and Recurrent KIF21A Mutations in Congenital Fibrosis of the Extraocular Muscles Type 1 and 3
Arch Ophthalmol, March 1, 2008; 126(3): 388 - 394.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
E. C. Engle
Genetic Basis of Congenital Strabismus
Arch Ophthalmol, February 1, 2007; 125(2): 189 - 195.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
T Tukel, A Uzumcu, A Gezer, H Kayserili, M Yuksel-Apak, O Uyguner, S H Gultekin, H-C Hennies, P Nurnberg, R J Desnick, et al.
A new syndrome, congenital extraocular muscle fibrosis with ulnar hand anomalies, maps to chromosome 21qter
J. Med. Genet., May 1, 2005; 42(5): 408 - 415.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
P Aubourg, M Krahn, R Bernard, K Nguyen, O Forzano, I Boccaccio, V Delague, A De Sandre-Giovannoli, J Pouget, D Depetris, et al.
Assignment of a new congenital fibrosis of extraocular muscles type 3 (CFEOM3) locus, FEOM4, based on a balanced translocation t(2;13) (q37.3;q12.11) and identification of candidate genes
J. Med. Genet., March 1, 2005; 42(3): 253 - 259.
[Full Text] [PDF]


Home page
J. Med. Genet.Home page
M Michaelides and A T Moore
The genetics of strabismus
J. Med. Genet., September 1, 2004; 41(9): 641 - 646.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. Yamada, W.-M. Chan, C. Andrews, T. M. Bosley, E. C. Sener, J. T. Zwaan, P. B. Mullaney, B. T. Ozturk, A. N. Akarsu, L. J. Sabol, et al.
Identification of KIF21A Mutations as a Rare Cause of Congenital Fibrosis of the Extraocular Muscles Type 3 (CFEOM3)
Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2218 - 2223.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. C. Engle and R. J. Leigh
Genes, brainstem development, and eye movements
Neurology, August 13, 2002; 59(3): 304 - 305.
[Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
T F W McMullan and A G Tyers
X linked dominant congenital isolated bilateral ptosis: the definition and characterisation of a new condition
Br. J. Ophthalmol., January 1, 2001; 85(1): 70 - 73.
[Abstract] [Full Text]


Home page
Arch OphthalmolHome page
E. C. Sener, B. A. Lee, B. Turgut, A. N. Akarsu, and E. C. Engle
A Clinically Variant Fibrosis Syndrome in a Turkish Family Maps to the CFEOM1 Locus on Chromosome 12
Arch Ophthalmol, August 1, 2000; 118(8): 1090 - 1097.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Association for Research in Vision and Ophthalmology